Dendreon Corp fka DNDNQ

[croumagnon]

"this seems a very non-trivial suit"

The 483 issue and the fact that DNDN management knew about it before the insider sales is a non-trivial suit for sure. I also suspect that DNDN management were aware of the faux pas they did by selling shares and that is why they were very defensive at the CC following the "approvable letter" to emphasize the fact that the CMC issues raised by the FDA were trivial and easily addressable...